Drug factory · FDA FEI 3007801780
Eurofins Advantar Laboratories, LLC
5451 Oberlin Drive #100, San Diego, CA, United States
Problems found, fixed voluntarily at FDA's last inspection, Jun 30, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2016: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Pegcetacoplan | Tests it | Apellis Pharmaceuticals, Inc. | 73606-010, 73606-020 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 30, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 5, 2021 | No problems found | Drug Quality Assurance | — |
| Feb 3, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; label; manufacture; pack; relabel; repack; sterilize.